Susquehanna International Group’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-37,793
| Closed | -$113K | – | 6719 |
|
|
2024
Q2 | $113K | Buy |
37,793
+1,143
| +3% | +$3.42K | ﹤0.01% | 5054 |
|
|
2024
Q1 | $126K | Buy |
+36,650
| New | +$126K | ﹤0.01% | 4920 |
|
|
2022
Q3 | – | Sell |
-4,327
| Closed | -$22K | – | 7021 |
|
|
2022
Q2 | $22K | Buy |
+4,327
| New | +$22K | ﹤0.01% | 5405 |
|
|
2020
Q4 | – | Sell |
-1,274
| Closed | -$12K | – | 5386 |
|
|
2020
Q3 | $12K | Buy |
+1,274
| New | +$12K | ﹤0.01% | 4325 |
|
|
2018
Q1 | – | Sell |
-11,663
| Closed | -$528K | – | 4675 |
|
|
2017
Q4 | $528K | Buy |
+11,663
| New | +$528K | ﹤0.01% | 2357 |
|
|
2015
Q1 | – | Sell |
-49
| Closed | -$12K | – | 4550 |
|
|
2014
Q4 | $12K | Buy |
+49
| New | +$12K | ﹤0.01% | 4340 |
|